A Review of Butyrylcholinesterase as a Therapeutic Target in the Treatment of Alzheimer’s Disease

Nordberg, Agneta, Ballard, Clive, Bullock, Roger, Darreh-Shori, Taher, Somogyi, Monique·2013·The Primary Care Companion For CNS Disorders
DOI 10.4088/pcc.12r01412

Cited by (351)

Items 201–300 of 351

  1. Novel conjugates of 4-amino-2,3-polymethylenequinolines and vanillin as potential multitarget agents for AD treatment
    Галина Ф. Махаева, Igor V. Serkov, Надежда Владимировна Ковалева, Елена Владимировна Рудакова, Natalia P. Boltneva, Ekaterina A. Kochetkova, Alexey N. Proshin, Сергей Олегович Бачурин · 2021 · Mendeleev Communications
  2. The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease
    Maria Podsiedlik, Magdalena Markowicz-Piasecka, Joanna Sikora · 2022 · International Journal of Molecular Sciences
  3. Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes
    Diba Shareghi-Boroujeni, Aida Iraji, Mahintaj Dara, Mohammad Hashem Hashempur, Shahrokh Zare, Roshanak Hariri, Tahmineh Akbarzadeh, Mina Saeedi · 2024 · Future Medicinal Chemistry
  4. Synthesis of α-Naphthalene Acetic Acid Derived Bis -Schiff Bases: In Vitro Cholinesterase Inhibition, Molecular Docking, Dynamics Simulations, Kinetics, and DFT Analysis
    Amrina Bibi, Aftab Alam, Tanzeela Ahmad Shah, Burak Tüzün, Imtiaz Ahmad, Muhammad Ayaz, Sajjad Ur Rahman, Ahmed A. Elhenawy, Syed Adnan Alı Shah, Abdul Latif et al. · 2025 · Polycyclic aromatic compounds
  5. Synthesis, biological evaluation and molecular modeling studies of substituted N -benzyl-2-phenylethanamines as cholinesterase inhibitors
    Florencia Carmona-Viglianco, Daniel Zaragoza-Puchol, Oscar Parravicini, Adriana Garro, Ricardo Daniel Enriz, Gabriela E. Feresin, Marcela Kurina‐Sanz, Alejandro A. Orden · 2020 · New Journal of Chemistry
  6. Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
    Muhammad Sani, Yahaya Tijani, Madu Adamu Gadaka, Babagana Modu, Miriam Watafua, Hadiza Ali Ahmad, Umar Abdullahi Zakariyya, Aminu Ibrahim, Aliyu Daja, Hassan Zanna et al. · 2022 · Heliyon
  7. Butyrylcholinesterase in Substance Abuse: An Overview
    Syed M. Nurulain, Abdu Adem, Shahzad Munir, Rabia Habib, Sliha Awan, Fozia Anwar, Sajida Batool · 2020 · Neurophysiology
  8. Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System
    Kun Bu, Devashru Patel, Robert Morris, Weiru Han, Gibret Umeukeje, Tianrui Zhu, Feng Cheng · 2022 · Journal of Alzheimer s Disease
  9. Glycoengineering of Esterase Activity through Metabolic Flux‐Based Modulation of Sialic Acid
    Mohit Philip Mathew, Elaine Tan, Jason W. Labonte, Shivam Shah, Christopher T. Saeui, Lingshu Liu, Rahul Bhattacharya, Patawut Bovonratwet, Jeffrey J. Gray, Kevin J. Yarema · 2017 · ChemBioChem
  10. Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors
    Галина Ф. Махаева, Надежда Владимировна Ковалева, Sofya V. Lushchekina, Елена Владимировна Рудакова, Natalia P. Boltneva, Alexey N. Proshin, B. V. Lednev, Igor V. Serkov, Сергей Олегович Бачурин · 2018 · Doklady Biochemistry and Biophysics
  11. Neuroprotective Effects of Blueberries through Inhibition on Cholinesterase, Tyrosinase, Cyclooxygenase-2, and Amyloidogenesis
    Pari Samani, Sophia Costa, Shuowei Cai · 2023 · Nutraceuticals
  12. Evaluating the Effect of Adding Selected Herbs, Spices, and Fruits to Fermented Olympus Mountain Tea (Sideritis scardica) Kombucha Sweetened with Thyme Honey: Assessment of Physicochemical and Functional Properties
    Ioannis Geraris Kartelias, Ioannis Panagiotakopoulos, Constantina Nasopoulou, Haralabos Christos Karantonis · 2024 · Beverages
  13. Repurposing Duloxetine as a Potent Butyrylcholinesterase Inhibitor: Potential Cholinergic Enhancing Benefits for Elderly Individuals with Depression and Cognitive Impairment
    Taher Darreh‐Shori, Anurag T. K. Baidya, Medea Brouwer, Amit Kumar, Rajnish Kumar · 2024 · ACS Omega
  14. Synthesis, biological activities and computational studies of bis-Schiff base derivatives of 4-hydroxyacetophenone: insights from an in vitro , molecular docking and dynamics simulation approach
    Gul Badshah, Aftab Alam, Muhammad Ayaz, Ahmed A. Elhenawy, Imtiaz Ahmad, Shujaat Ahmad, Muhammad Usman, Ashwag S. Alanazi, Abdul Latif, Mumtaz Ali et al. · 2025 · RSC Advances
  15. A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease
    Wei Liu, Yuqiang Wang, Moussa B. H. Youdim · 2022 · Ageing and Neurodegenerative Diseases
  16. Unveiling Neuroprotective Potential of Spice Plant-Derived Compounds against Alzheimer’s Disease: Insights from Computational Studies
    Md. Murshid Alom, Rejwana Parvin Bonna, Ariful Islam, Md. Wasim Alom, Md. Ekhtiar Rahman, Md Omar Faruqe, M Khalekuzzaman, Rashed Zaman, Md. Asadul Islam · 2023 · International Journal of Alzheimer s Disease
  17. Polymethoxyflavones transcends expectation, a prominent flavonoid subclass from Kaempferia parviflora: A critical review
    Mohammad Aidiel, Maisarah Abdul Mutalib, Khalisanni Khalid, Nik Nasihah Nik Ramli, Shirley Gee Hoon Tang, Siti Hajar Adam · 2023 · Arabian Journal of Chemistry
  18. Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder
    Sadaf Munir, Rabia Habib, Sliha Awan, Nazia Bibi, Arooj Tanveer, Sajida Batool, Syed M. Nurulain · 2019 · Journal of Molecular Neuroscience
  19. Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer’s Disease
    Jianping Jia, Yong Ji, Tao Feng, Qinyong Ye, Dantao Peng, Weihong Kuang, Yuping Ning, Zhihou Liang, Dongsheng Fan, Wenshi Wei et al. · 2019 · Journal of Alzheimer s Disease
  20. Enhanced Contextual Fear Memory and Elevated Astroglial Glutamate Synthase Activity in Hippocampal CA1 BChE shRNA Knockdown Mice
    Si Xuan Chen, Zhengdong Lin, Kai-Leng Tan, Risheng Chen, Wenfang Su, Haishan Zhao, Qiwen Tan, Wen Tan · 2020 · Frontiers in Psychiatry
  21. Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules
    Alka Ashok Singh, Fazlurrahman Khan, Minseok Song · 2025 · International Journal of Molecular Sciences
  22. Transdermal rivastigmine in the treatment of Alzheimer’s disease: current and future directions
    Hamid Reza Amanatkar, George Thomas Grossberg · 2014 · Expert Review of Neurotherapeutics
  23. Clinanthus microstephium, an Amaryllidaceae Species with Cholinesterase Inhibitor Alkaloids: Structure−Activity Analysis of Haemanthamine Skeleton Derivatives
    Tonino G. Adessi, José L. Borioni, Natalia B. Pigni, Jaume Bastida, Valéria Cavallaro, Ana Paula Murray, Marcelo Puiatti, Juan Carlos Oberti, Segundo Leiva G., Viviana Estela Nicotra et al. · 2019 · Chemistry & Biodiversity
  24. Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase
    Christian Gentzsch, Xinyu Chen, Philipp Spatz, Urban Košak, Damijan Knez, Naoko Nose, Stanislav Gobec, Takahiro Higuchi, Michael W. Decker · 2021 · Molecular Imaging and Biology
  25. Synthesis, Molecular Modeling and Cholinesterase Inhibitory Effects of 2-Indolinone-Based Hydrazinecarbothioamides
    Kübra Demir-Yazıcı, Çağla Begüm Apaydın, Özge Soylu Eter, Nurten Özsoy, Nilgün Karalı · 2021 · Future Medicinal Chemistry
  26. Interplay Between Endocannabinoid System and Neurodegeneration: Focus on Polypharmacology
    Francesca Seghetti, Silvia Gobbi, Federica Belluti, Angela Rampa, Alessandra Bisi · 2021 · Current Medicinal Chemistry
  27. Synthesis and cholinesterase inhibitory activity study of Amaryllidaceae alkaloid analogues with N -methyl substitution
    Petr Jansa, Ivan Barvı́k, Daniela Hulcová, Eliška Matoušová · 2022 · Organic & Biomolecular Chemistry
  28. Trimethoxycinnamates and Their Cholinesterase Inhibitory Activity
    Jiří Kos, Tomáš Strhársky, Šárka Štěpánková, Katarína Svrčková, Michal Oravec, Jan Hošek, Aleš Imramovský, Josef Jampílek · 2021 · Applied Sciences
  29. Bis-γ-carbolines as new potential multitarget agents for Alzheimer’s disease
    Галина Ф. Махаева, E. F. Shevtsova, Aleksey Yu. Aksinenko, Надежда Владимировна Ковалева, Natalia P. Boltneva, Sofya V. Lushchekina, Елена Владимировна Рудакова, Elena A. Pushkareva, Tatyana P. Serkova, L. G. Dubova et al. · 2020 · Pure and Applied Chemistry
  30. A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade
    Nadia Olivier, Brian Herbert Harvey, Stanislav Gobec, Mohammed Shahid, Urban Košak, Simon Žakelj, Christiaan Beyers Brink · 2025 · Biomedicine & Pharmacotherapy
  31. Neuroprotective potential of Viburnum orientale Pallas through enzyme inhibition and antioxidant activity assays
    İlkay Erdoğan Orhan, Fatma Sezer Şenol, Betül Sever Yılmaz, Mehmet Levent Altun, Serkan Özbilgin, Ayşe Nur Yazgan Ekici, Emrah YÜKSEL, G.S. İşcan · 2017 · South African Journal of Botany
  32. Novel aryl(4-phenylpiperazin-1-yl)methanethione derivatives as new anti-Alzheimer agents: Design, synthesis, in vitro and in silico assays
    Samira Ansari, Milad Noori, Keyvan Pedrood, Maryam Mohammadi‐Khanaposhtani, Ali Moazzam, Samanesadat Hosseini, Bagher A. Larijani, Hossein Adibi, Mahmood Biglar, Haleh Hamedifar et al. · 2022 · Journal of Molecular Structure
  33. Novel Multipotent Amantadine–M30D Hybrids with Highly Selective Butyrylcholinesterase Inhibition and Neuroprotective Effects as Effective Anti-Alzheimer’s Agents
    Marlyn Stephany Rada, Wilson Cardona‐Galeano, Jorge Quintero‐Saumeth, Karina Sierra, Edison Osorio, Luis Alfonso González-Molina, Rafael Posada‐Duque, A.F. Yepes · 2022 · ACS Chemical Neuroscience
  34. New insights into the interaction between mammalian butyrylcholinesterase and amitriptyline: a combined experimental and computational approach
    Kerem Teralı, Özlem Dalmızrak, Sani Muhammad Uzairu, Nazmi Özer · 2018 · Turkish Journal of Biochemistry
  35. Effect of the Cycle Size and Spacer Structure in Tacrine and its Cyclopentyl Homologue Conjugates with 5-(4-trifluoromethyl-phenylamino)-1,2,4-thiadiazole on the Spectrum of their Biological Activity
    Надежда Владимировна Ковалева, Alexey N. Proshin, Елена Владимировна Рудакова, Natalia P. Boltneva, Igor V. Serkov, Галина Ф. Махаева · 2018 · Biomedical Chemistry Research and Methods
  36. Chemical composition, biological properties and bioinformatics analysis of two Caesalpina species: A new light in the road from nature to pharmacy shelf
    Gökhan Zengin, Mohamad Fawzi Mahomoodally, Marie Carene Nancy Picot-Allain, Kouadio Ibrahime Sinan, Güneş Ak, Ouattara Katinan Etienne, Elwira Sieniawska, Magdalena Maciejewska‐Turska, Łukasz Świątek, Barbara Rajtar et al. · 2021 · Journal of Pharmaceutical and Biomedical Analysis
  37. Computational and experimental studies on the interaction between butyrylcholinesterase and fluoxetine: implications in health and disease
    Özlem Dalmızrak, Kerem Teralı, Osman Yetkin, İ. Hamdi Öğüş, Nazmi Özer · 2018 · Xenobiotica
  38. Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer’s Disease
    Milad Noori, Minoo Khalili Ghomi, Navid Dastyafteh, Najmeh Oliyaei, Haleh Hamedifar, Shahrzad Javanshir, Nader Tanideh, Elahe Sattarinezhad, Fateme Sattari, M Haghani et al. · 2024 · ACS Omega
  39. Xanthones as neuroprotective agents: A comprehensive review of their role in the prevention and treatment of neurodegenerative diseases
    Dibyajyoti Das, Aparoop Das, Kunal Bhattacharya, Kinku Pritam Koch, Dhirak Jyoti Deuri, Dipankar Saikia, Nongmaithem Randhoni Chanu, Satyendra Deka · 2025 · Ageing Research Reviews
  40. New biologically active sulfonamides as potential drugs for Alzheimer's disease
    Marie Nevyhoštěná, Alena Komersová, Vladimír Pejchal, Šárka Štěpánková, Petr Česla, Kevin Matzick, Jana Macháčková, Roman Svoboda · 2024 · Archiv der Pharmazie
  41. Phenylstyrylpyrimidine derivatives as potential multipotent therapeutics for Alzheimer's disease
    Bharti Devi, Kailash Jangid, Vijay Kumar, Tania Arora, Naveen Kumar V, Ashish Ranjan Dwivedi, Jyoti Parkash, Vinod Kumar · 2024 · RSC Medicinal Chemistry
  42. Effect of curcumin–donepezil combination on spatial memory, astrocyte activation, and cholinesterase expressions in brain of scopolamine-treated rats
    Opeyemi Babatunde Ogunsuyi, Omodesola Oluwafisayo Ogunruku, Haruna Isiyaku Umar, Ganiyu Oboh · 2024 · Molecular Biology Reports
  43. Quinazolinone–Hydrazine Cyanoacetamide Hybrids as Potent Multitarget-Directed Druggable Therapeutics against Alzheimer’s Disease: Design, Synthesis, and Biochemical, In Silico, and Mechanistic Analyses
    Kandrakonda Yelamanda Rao, Chandran Remya, Kalarickal Vijayan Dileep, Gorantla Sri Charitha, Shaik Jeelan Basha, Sreelakshmi Mothukuru, Irla Sivakumar, Vamsi Katta, Sandeep Kumar, Aramati B. M. Reddy et al. · 2024 · ACS Chemical Neuroscience
  44. Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
    Shubhangi D. Shirsat, Chunyi Li, Zhipeng Liu, Varenyam Achal, Olivier Habimana · 2025 · Scientific Reports
  45. Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer’s Disease
    Patricia Del Cerro, Carolina Alquézar, Fernando Benito Bartolomé, Pedro González-Naranjo, Concepción Pérez, Eva Carro, Juan Antonio Paez, Nuria Eugenia Campillo, Ángeles Martín‐Requero · 2018 · CNS Drugs
  46. The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening
    Michael D. Gambardella, Yigui Wang, Jiongdong Pang · 2024 · Molecules
  47. A multi enzyme study reviewing the role of target enzymes in Alzheimer’s disease and unveiling potential inhibitors with insights on their present and future assessment
    Syed Bassam Zaki, Sahar Afzal Khan, Ruhi Ali · 2025 · Medicinal Chemistry Research
  48. HPLC-DAD profiling, antioxidant, anticholinesterase, and antidiabetic activities of four Algerian edible plant extracts: An in vitro and in silico study
    Djihad Eladaouia Siga, Boulanouar Bakchiche, Cansel Çakır, Kübra Tuna, Mehmet Öztürk, Aissa Tounsi, Rehab Sabour, Mosad Ahmed Ghareeb · 2025 · South African Journal of Botany
  49. Synthesis, enzyme inhibition and molecular docking studies of novel 1,2,4-oxadiazole thioether derivatives
    Nevin Arıkan Ölmez, Samir Abbas Ali Noma, Yunus Kaya, Bilgen Osman · 2024 · Medicinal Chemistry Research
  50. Antidiabetic, Antidepressant, Antiparkinson’s, Neuroprotective, and Antioxidant Potentials of Novel Schiff Base Derivatives of a Lichen Metabolite, Usnic Acid
    Lawali Yabo-Dambagi, A. Cakir, Ayşegül Karaküçük‐İyidoğan · 2024 · Russian Journal of Bioorganic Chemistry
  51. N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer’s Disease Therapy
    Eugenie Nepovimová, Jan Korábečný, Vendula Hepnarová, Daniel Jun, Rafael Doležal, Ľubica Múčková, Petr Jošt, Ondřej Soukup, Jana Janočková, Ngoc Lam Pham et al. · 2019 · Current Alzheimer Research
  52. Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias
    Landon Perlett, Eric Edward Smith · 2022 · Clinics in Geriatric Medicine
  53. Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia
    Beate Mueller, Georg Adler · 2015 · World Journal of Neuroscience
  54. Progressive Insights into the Pharmacological Importance of Isoquinoline Derivatives in Modern Therapeutics
    Kishor R. Danao, Pooja M. Malghade, Debarshi Kar Mahapatra, Meha N. Motiwala, Ujwala Mahajan · 2021 · International Journal of Current Research and Review
  55. Mutivariate optimization strategy for the sonication-based extraction of Nardostachys jatamansi roots and analysis for chemical composition, anti-oxidant and acetylcholinesterase inhibitory potential
    Ashwani Arya, Vineet Mittal, Deepak Kumar Kaushik, Manish Kumar, Saqer S. Alotaibi, Sarah M. Albogami, Gaber El‐Saber Batiha, Philippe Jeandet · 2022 · Ultrasonics Sonochemistry
  56. INHIBITION OF CHOLINESTERASES BY WATER-SOLUBLE PALM FRUIT EXTRACT
    Soon-Sen Leow · 2021 · Journal of Oil Palm Research
  57. 8-Hydroxyquinoline Derivatives as Drug Candidates for the Treatment of Alzheimer's Disease
    Pedro F. Bartolomeu, Isadora Serraglio Fortes, Aline Rigon Zimmer, Marcela Silva Lopes, Saulo Fernandes de Andrade · 2025 · Current Medicinal Chemistry
  58. A Computational Study of Phenothiazine Derivatives as Acetylcholinesterase Inhibitors Targeting Alzheimer’s Disease
    V. Prema, Meena A., Narayanan Ramalakshmi · 2024 · Central Nervous System Agents in Medicinal Chemistry
  59. CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the 3xTg Mouse Model of Alzheimer’s Disease by Multiple Actions in the Pathology
    Humberto Martínez-Orozco, Alberto Bencomo-Martínez, Juan Pablo Maya-Arteaga, Pedro Francisco Rubio-De Anda, Fausto Sanabria-Romero, Zyanya Gloria Mena Casas, Isaac Vargas-Rodríguez, Gabriela Hernández‐Puga, Marquiza Sablón-Carrazana, Roberto Menéndez-Soto del Valle et al. · 2025 · International Journal of Molecular Sciences
  60. Application of computational methods in the drug discovery and development of Alzheimer's disease
    Qianqian Zhang, Xiaoqing Gong, Huanxiang Liu, Xiaojun Yao · 2025 · Acta Pharmaceutica Sinica B
  61. Role of dietary phytopharmaceuticals across the globe to alleviate the Alzheimer’s disease: mechanism-based approach
    Arun Kumar Mishra, Amrita Mishra, Kamal YT, Arvind Kumar, Harpreet Singh, Shristy Verma, Gyas Khan · 2025 · Phytomedicine Plus
  62. The Role of the Cholinergic System in Lung Diseases
    Vedran Milanković, Tamara D. Lazarević Pašti · 2021 · Springer eBooks
  63. Assay Suitability for Natural Product Screening: Searching for Leads to Fight Alzheimerʼs Disease
    Mervi Vasänge · 2014 · Planta Medica
  64. Exploration of the Chemical Components and Biological Activities of Hippophae salicifolia Extracts: In Vitro, Molecular Docking, and MD Simulation Approaches
    Devesh Tewari, Nitish Singh Jangwan, Sweta Roy, Neeraj Choudhary, Saurabh Tarun Mishra, Anoop Kumar, Zoltán Cziáky, József Jekő, Gökhan Zengin · 2025 · Chemistry & Biodiversity
  65. Evaluation of Antioxidant and Enzyme Inhibitory Properties of Cinnamaldehyde: In Vitro and In Silico Investigations
    Jihane Touhtouh, Mustapha Laghmari, Taoufiq Benali, Tarik Aanniz, Khaoula Habbadi, Gökhan Zengin, Hooi‐Leng Ser, Khang Wen Goh, Bey-Hing Goh, Abdelhakim Bouyahya et al. · 2026 · Journal of Chemistry
  66. Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated/ N-Tiophosphorylated Tacrine
    Maja Przybyłowska, Iwona Inkielewicz‐Stępniak, Szymon Kowalski, Krystyna Dzierzbicka, Sebastian Demkowicz, Mateusz Daśko · 2019 · Medicinal Chemistry
  67. Implications of atrazine concentrations in drinking water from Ijebu-North, Southwest Nigeria on the hypothalamic-pituitary-adrenal axis
    Folarin Ojo Owagboriaye, Oladunni Nimota Adekunle, Rasheed Yemi Oladunjoye, Mistura Temitope Adeleke, Sulaimon Adebisi Aina, Adedamola Adenekan, Pamilerin Bakare, Oyebamiji Oladeni Fafioye, Gabriel Adewunmi Dedeke, Olusegun Adebayo Lawal · 2023 · Drug and Chemical Toxicology
  68. Virtual screening of drugs against multiple targets of Alzheimer's disease
    Karin Ben Zaken, Samuel Mesfin, Naamah Bloch, Abraham O. Samson · 2025 · Journal of Alzheimer s Disease
  69. Advances in 1,3,4-thiadiazole-based cholinesterase inhibitors: toward novel therapeutics for Alzheimer’s disease
    Moksh Shah, Kripa Patel, Utkarsha Kulkarni, Mange Ram Yadav, Ashish Patel, Afzal Nagani · 2026 · Molecular Diversity
  70. Rethinking common solvents in butyrylcholinesterase activity assays
    Umar Muhammad Ghali, Kerem Teralı, Özlem Dalmızrak, Nazmi Özer · 2022 · Inorganic Chemistry Communications
  71. Combination Of Riluzole And Rivastigmine- A Potential Treatment Strategy For Alzheimer’s Disease
    2023 · Journal of Population Therapeutics and Clinical Pharmacology
  72. Insilico Screening of Pentacyclic Triterpenoids against Vascular Dementia Target’s
    Rathna Roja, Kalakotla Shanker, Arun Reddy Ravula, Hemanth Kumar Boyina, S.K. Navanita, Pillalamarri Bala Sri Vallika, Kiran Gangarapu, Krishna Prasad Devarakonda, Vasudha Bakshi · 2023 · Advances in experimental medicine and biology
  73. Novel Therapeutic Approaches in Alzheimer's Disease
    Pravinkumar Vishwanath Ingle, Yen Ling Lee, Xin Yun Wong, Sok Pei Tan, Ee Jun Lim, Mei Yu Chin, Michelle Chieng Shu Zhen, Nurul Hasyanazifa binti Safian, Ketan Vinayakrao Hatware · 2024 · Current Drug Therapy
  74. Unlocking the potential: Woodfordia fruticosa Kurz in Alzheimer's disease management - A concise review
    Sanjukta Sen, Shreyasi Meur, Gouranga Nandi, Dipanjan Karati · 2024 · Brain Disorders
  75. Syzygium cumini fresh juice ameliorated memory impairment in a scopolamine-induced amnesic mouse model through active avoidance paradigm
    Nosheen Malik, Hammad Murtaza, Waseem Ashraf, Muhammad Fawad Rasool, Farhan Siddique, Maryam Bashir, Tanveer Ahmad, Faleh Alqahtani, Imran Imran · 2024 · Journal of Functional Foods
  76. Molecular Dynamics Studies on the Inhibition of Cholinesterases by Secondary Metabolites
    Michael D. Gambardella, Yigui Wang, Jiongdong Pang · 2025 · Catalysts
  77. НОВЫЕ КОНЪЮГАТЫ ТАКРИНА С ПРОИЗВОДНЫМИ 1,2,4-ТИАДИАЗОЛА - ВЫСОКОЭФФЕКТИВНЫЕ ИНГИБИТОРЫ ХОЛИНЭСТЕРАЗ, БЛОКАТОРЫ NMDA-РЕЦЕПТОРОВ И АНТИОКСИДАНТЫ, "Доклады Академии наук"
    Галина Ф. Махаева, Н.В. Ковалева, Владимир Викторович Григорьев, Alexey N. Proshin, Елена Владимировна Рудакова, Natalia P. Boltneva, Igor V. Serkov, Сергей Олегович Бачурин · 2017 · Доклады Академии наук
  78. Potential targeting sites in brain and brain tumors
    Atinderpal Kaur, Surbhi Sharma, Afeefa Noor, Shweta Dang, Sushama Talegaonkar · 2022 · Elsevier eBooks
  79. In Vitro Evaluation of Serine Hydrolase Inhibitors
    Carey Pope, Kirstin Hester, Lester G. Sultatos · 2018 · Methods in pharmacology and toxicology
  80. Immunohistochemistry for acetylcholinesterase and butyrylcholinesterase in the dorsal motor nucleus of the vagus (DMNV) of formalin-fixed, paraffin-embedded tissue: comparison with reported literature
    Masarra Al Deleemy, Benjamin Huynh, Karen Ann Waters, Rita Machaalani · 2022 · Histochemistry and Cell Biology
  81. Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
    Ahmet Ozan ÖZGEN, Ozan Emre Eyüpoğlu · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  82. Exploring the Hydrazone Group in Multifunctional Approaches for Alzheimer's Disease Therapy
    Carola Grondona, Eleonora Russo, Bruno Tasso · 2026 · ChemMedChem
  83. How distillation alters bioactivity: Comparative phytochemical and biological evaluation of three Lamiaceae species (Origanum sipyleum, Thymus sipyleus, and Sideritis phrygia) before and after distillation
    Gökhan Zengin, Shakeel Ahmed, Kouadio Ibrahime Sinan, Stefano Dall’Acqua, Selami Selvı, Umut Karğılı, Güneş Ak, Enver Saka, Bengusu H. Akgul, Milena Terzić · 2026 · Microchemical Journal
  84. Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives
    Sandeep Bindra, Won Kyeong Jeong, Muzammil Kabi̇er, Sunil Kumar, Sachithra Thazhathuveedu Sudevan, Harish Chandra Vishwakarma, Della Grace Thomas Parambi, Naseer Maliyakkal, Umesh Kumar, Leena K. Pappachen et al. · 2026 · Chemistry & Biodiversity
  85. Therapeutic Efficacy of Natural Phytochemicals as Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
    Adnan Ahmad, Krishan Pal · 2022 · Journal of Ecophysiology and Occupational Health
  86. Investigation of 3-Phenylcoumarin Derivatives as Potential Multi-target Inhibitors for Human Cholinesterases and Monoamine oxidases: A Computational Approach
    Ammara Fayyaz, Syeda Abida Ejaz, Bshra Ali A. Alsfouk, Syeda Rabia Ejaz · 2024 · Applied Biochemistry and Biotechnology
  87. Comparing Acetylcholinesterase and Butyrylcholinesterase Inhibition Effect of Total Extract and Fractions with Alcaloid-Rich Extract of Huperzia Serrata (Thunb.) Trevis.
    Hoai Thi Thu Nguyen, Nguyễn Thùy Dương, Bùi Thanh Tùng, Dao Thi Vui, Dang Kim Thu · 2020 · VNU Journal of Science Medical and Pharmaceutical Sciences
  88. Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders
    Jan Korábečný · 2018 · Česká a slovenská farmacie
  89. Privileged Multi-Target Directed Propargyl-Tacrines Combining Cholinesterase and Monoamine Oxidase Inhibition Activities
    Žofia Chrienová, Eugenie Nepovimová, Rudolf Andrýs, Rafael Doležal, Jana Janočková, Ľubica Múčková, Lenka Nemcikova, Ondřej Soukup, Patrik Olekšák, Martin Vališ et al. · 2022 · SSRN Electronic Journal
  90. Meðferðarúrræði við Alzheimerssjúkdómnum : lyf og lyfleysur
    Erla Steinunn Árnadóttir · 2014
  91. Guanidinoacetate alters antioxidant defenses and butyrylcholinesterase activity in the blood of rats
    Guilherme André Eger, Vinícius Vialle Ferreira, Camila Ribeiro Batista, Daniela Delwing de Lima, Ângela Terezinha de Souza Wyse, Júlia Niehues da Cruz, Débora Delwing Dal Magro, José Geraldo Pereira da Cruz · 2015 · Clinical & Biomedical Research
  92. Optical Detection of Interaction between Alzheimer's Disease Biomarkers and Carbon Nanotubes
    Amina Zaheer · 2014 · TSpace (University of Toronto)
  93. Design, Synthesis and Acetylcholinesterase and Butylcholinesterase Inhibition Activity of Novel 1-(Alkyl)-3-(2-oxo-2H-chromenyloxy Acetamido) methylpyridinium Salts
    Mehri Abdollahi fard, Mohammadreza Manafi, Manijeh Motevalian, Seyed Saied Homami · 2020 · Letters in Organic Chemistry
  94. Evaluation of neuroprotective activity of isolated fraction from Biophytum sensitivum on #945;-(hydroxymethyl) Benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo non-7-yl ester induced dementia in rats
    Nagaraju Bandaru, Ramu A, S Vidhyadhara · 2020 · Journal of Pharmacognosy and Phytochemistry
  95. Dietary Polyphenols and Neuroprotection
    Rui F. M. Silva, Lea Pogačnik · 2022 · MDPI eBooks
  96. Asociación entre el déficit colinérgico, las disfunciones de la memoria y el metabolismo energético en un modelo de rata
    Rebeca Martínez Quezada · 2013
  97. Cholinesterase Research
    Jan Korábečný, Ondřej Soukup · 2021 · MDPI eBooks
  98. Identification of Herbal Molecules for the Treatment of Alzheimer's Disease Through a Combination of Molecular Docking and In-Vitro Analysis
    Priyanka Nagu, Amjad Khan A Pathan, Vineet Mehta · 2023 · Journal of Scientific & Industrial Research
  99. Occurrence of butyrylcholinesterase polymorphisms in patients undergoing surgery in Slovakia.
    Lukáš Čuchrač, Marta Mydlárová Blaščáková, Jozef Firment, J Šimonová, Jarmila Bernasovská, Janka Vašková · 2023 · PubMed Central
  100. Exploring avenues for Alzheimer’s drugs: current status and future outlook
    Karishma Manohar Rathi, Ravindra D. Wavhale, V. Undale V., Ritesh P. Bhole, Snehal D. Dherange · 2024 · Russian neurological Journal